Education
About Us
Working with TipRanks
Follow Us
Robert Charles Breedlove Insider Profile
4 Followers
Robert Charles Breedlove, CAO at Phathom Pharmaceuticals, holds 53.50K shares in Phathom Pharmaceuticals (Ticker: PHAT). Most recently, Robert Charles Breedlove Sold $1,692 shares of Phathom Pharmaceuticals on Jul 18, 2025 for an estimated value of 14.15K.
Robert Charles Breedlove has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert Charles Breedlove's holdings
Insider Roles
CAO
Roles that Robert Charles Breedlove holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Charles Breedlove
Robert Charles Breedlove's Trading History
List of latest transactions for each holding click on a transaction to see Robert Charles Breedlove's performance on stock
You May Also Like
Robert Charles Breedlove insider profile FAQ
What is the percentage of profitable transactions made by Robert Charles Breedlove?
The percentage of profitable transactions made by Robert Charles Breedlove is ―.
What is the average return per transaction made by Robert Charles Breedlove?
The average return per transaction made by Robert Charles Breedlove is ―.
What stocks does Robert Charles Breedlove hold?
Robert Charles Breedlove holds: PHAT stocks.
What was Robert Charles Breedlove’s latest transaction?
Robert Charles Breedlove latest transaction was an Informative Sell of $14.15K.
What was Robert Charles Breedlove's most profitable transaction?
Robert Charles Breedlove’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Charles Breedlove's role in Phathom Pharmaceuticals?
Robert Charles Breedlove's role in Phathom Pharmaceuticals is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.